Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TECLISTAMAB-CQYV vs TEGASEROD: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TECLISTAMAB-CQYV vs TEGASEROD: Safety Overview

Metric TECLISTAMAB-CQYV TEGASEROD
Total FAERS Reports 1,592 102
Deaths Reported 338 2
Death Rate 21.2% 2.0%
Hospitalizations 395 13
Average Patient Age 68.9 yrs 62.0 yrs
% Female Patients 49.5% 81.1%
FDA Approval Date N/A Jul 24, 2002
Marketing Status Prescription Discontinued